Thrombin generation test based on a 96-channel pipettor for evaluation of FXIa procoagulant activity in pharmaceuticals.

Parunov, Leonid A; Shea, Maria E; Liang, Yideng; Surov, Stepan S; Chattopadhyay, Maitreyi; Lee, Timothy K; Scott, Dorothy E; Ovanesov, Mikhail V

Parunov, Leonid A; Shea, Maria E; Liang, Yideng; Surov, Stepan S; Chattopadhyay, Maitreyi; Lee, Timothy K; Scott, Dorothy E; Ovanesov, Mikhail V.

Affiliation

Parunov LA; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
Shea ME; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
Liang Y; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
Surov SS; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
Chattopadhyay M; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
Lee TK; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
Scott DE; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
Ovanesov MV; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. mikhail.ovanesov@fda.hhs.gov.

Nat Protoc ; 16(8): 3981-4003, 2021 08.

Article in En | MEDLINE | ID: mdl-34215864

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombin / Factor XIa / Anticoagulants Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: Nat Protoc Year: 2021 Document type: Article Affiliation country: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google